187420 — GenoFocus Balance Sheet
0.000.00%
- KR₩84bn
- KR₩124bn
- KR₩27bn
Annual balance sheet for GenoFocus, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 21,954 | 35,559 | 25,615 | 41,547 | 29,865 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 5,610 | 3,420 | 5,871 | 8,168 | 7,430 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 31,066 | 44,339 | 37,313 | 55,431 | 43,054 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 39,830 | 53,890 | 60,494 | 61,171 | 43,259 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 90,202 | 113,227 | 118,523 | 133,914 | 97,863 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 10,599 | 40,891 | 51,984 | 93,853 | 60,417 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 38,081 | 73,460 | 83,244 | 110,022 | 75,826 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
ESOP Debt Guarantee | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 52,121 | 39,767 | 35,279 | 23,892 | 22,037 |
Total Liabilities & Shareholders' Equity | 90,202 | 113,227 | 118,523 | 133,914 | 97,863 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |